References
- Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA 1999;281:249-54. https://doi.org/10.1001/jama.281.3.249
- Cathey SS, Kudo M, Tiede S, Raas-Rothschild A, Braulke T, Beck M, et al. Molecular order in mucolipidosis II and III nomenclature. Am J Med Genet A 2008;146A:512-3. https://doi.org/10.1002/ajmg.a.32193
- Sly W, Sundaram V. Genetic and metabolic diseases in pediatrics. London 1985:91-110.
- Okada S, Owada M, Sakiyama T, Yutaka T, Ogawa M. Icell disease: clinical studies of 21 Japanese cases. Clin Genet 1985;28:207-15.
- Kelly TE, Thomas GH, Taylor HA Jr., McKusick VA, Sly WS, Glaser JH, et al. Mucolipidosis III (pseudo-Hurler polydystrophy): Clinical and laboratory studies in a series of 12 patients. Johns Hopkins Med J 1975;137:156-75.
- Poenaru L, Castelnau L, Tome F, Boue J, Maroteaux P. A variant of mucolipidosis. II. Clinical, biochemical and pathological investigations. Eur J Pediatr 1988;147:321-7. https://doi.org/10.1007/BF00442708
- Spranger J. Bone dysplasia ‘families’. Pathol Immunopathol Res 1988;7:76-80. https://doi.org/10.1159/000157098
- Kornfeld S, Sly W. I-cell disease and Pseudo-Hurler Polydystrophy: disorders of lysosomal enzyme phosphorylation and localization. The Metabolic and Molecular Bases of Inherited Disease 2001;3469-82.
- Pazzaglia UE, Beluffi G, Bianchi E, Castello A, Coci A, Marchi A. Study of the bone pathology in early mucolipidosis II (I-cell disease). Eur J Pediatr 1989;148:553-7. https://doi.org/10.1007/BF00441557
- Unger S, Paul DA, Nino MC, McKay CP, Miller S, Sochett E, et al. Mucolipidosis II presenting as severe neonatal hyperparathyroidism. Eur J Pediatr 2005;164:236-43. https://doi.org/10.1007/s00431-004-1591-x
- Gelb BD, Shi GP, Chapman HA, Desnick RJ. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 1996;273:1236-8. https://doi.org/10.1126/science.273.5279.1236
- Ruivo R, Anne C, Sagne C, Gasnier B. Molecular and cellular basis of lysosomal transmembrane protein dysfunction. Biochim Biophys Acta 2009;1793:636-49. https://doi.org/10.1016/j.bbamcr.2008.12.008
- Robinson C, Baker N, Noble J, King A, David G, Sillence D, et al. The osteodystrophy of mucolipidosis type III and the effects of intravenous pamidronate treatment. J Inherit Metab Dis 2002;25:681-93. https://doi.org/10.1023/A:1022935115323
- Cavalcante WC, Santos LC, Dos Santos JN, de Vasconcellos SJ, de Azevedo RA, Dos Santos JN. Oral findings in patients with mucolipidosis type III. Braz Dent J 2012;23:461-6. https://doi.org/10.1590/S0103-64402012000400026
- Simsek-Kiper PO, Topaloglu R, Sahin Y, Utine GE, Boduroglu K. Mucolipidosis type III in an adolescent presenting with atypical facial features and skeletal deformities. Genet Couns 2013;24:7-12.
- Pantoja Zarza L, Diez Morrondo C. Skeletal deformities in mucolipidosis III. Reumatol Clin 2014;10:340-1. https://doi.org/10.1016/j.reuma.2013.10.001
- David-Vizcarra G, Briody J, Ault J, Fietz M, Fletcher J, Savarirayan R, et al. The natural history and osteodystrophy of mucolipidosis types II and III. J Paediatr Child Health 2010;46:316-22. https://doi.org/10.1111/j.1440-1754.2010.01715.x